Trademark search for:

IMBYODIF

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2021-07-01 — Application filed
2021-07-05 — Application filed
2021-07-30 — Teas petition to director-make special-received
2021-08-03 — Assigned to petition staff
2021-08-05 — Application filed
2021-08-05 — Petition to director - make special - granted
2021-08-05 — Assigned to examiner
2021-08-05 — Assigned to examiner
2021-08-10 — Examiners amendment -written
2021-08-10 — Examiners amendment e-mailed
2021-08-10 — Notification of examiners amendment e-mailed
2021-08-10 — Examiner's amendment entered
2021-08-11 — Approved for pub - principal register
2021-08-26 — Notification of notice of publication e-mailed
2021-09-14 — Published for opposition
2021-09-14 — Official gazette publication confirmation e-mailed
2021-10-01 — Extension of time to oppose received
2021-12-20 — Application abandoned
2021-12-28 — Application abandoned
2021-12-28 — Application abandoned
2021-12-28 — Final status recorded

Owner Information

Summit Therapeutics Inc.
Cambridge , MA

Correspondent

Andrew D. Bochner BOCHNER IP, PLLC
295 MADISON AVENUE
12TH FLOOR
NEW YORK, NY 10017

Filing Details

Filing Date:
2021-07-01

Status Date:
2021-12-28

Category:
Pharmaceuticals

Filing Year:
2021

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.